NCT02784340 Local and Intravenous Dexamethasone on Post Operative Pain a After CS Status COMPLETED Phase PHASE4
NCT02780609 Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02779283 Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT02773602 Dexamethasone or Clonidine as Adjuncts to Ropivacaine for Caudal Analgesia on Analgesia Duration in Children Status UNKNOWN Phase PHASE4
NCT02773030 A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02767219 The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery Status COMPLETED Phase PHASE3
NCT02765854 Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement Status COMPLETED Phase PHASE2
NCT02760459 Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial Status UNKNOWN Phase PHASE4
NCT02760043 Dexamethasone in Total Knee and Total Hip Arthroplasty Status UNKNOWN Phase PHASE2/PHASE3
NCT02755597 A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy Status COMPLETED Phase PHASE3
NCT02750670 Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT02741388 A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP Status COMPLETED Phase PHASE1
NCT02739035 MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty Status COMPLETED Phase PHASE4
NCT02736175 OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery Status COMPLETED Phase PHASE3